Atlas Trials

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

Clinical trial NCT00652054 · COMPLETED

Trial details

NCT number
NCT00652054
Sponsor
Taiho Oncology, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Cancer
Start date
2005-06-01
Primary completion
2007-06-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.